Staging in oesophageal cancer

Best Practice and Research: Clinical Gastroenterology

Volumn 20, Issue 5, 2006, Pages 877-891

  Plukker, J Th M ^a   van Westreenen, H L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

determination of response; oesophageal carcinoma; staging methods; treatment planning

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ACCURACY; ARTICLE; ASPIRATION BIOPSY; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC MUCOSAL RESECTION; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FALSE POSITIVE RESULT; HUMAN; INDIVIDUALIZATION; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MEDIASTINUM METASTASIS; MEDICAL DECISION MAKING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NON INVASIVE MEASUREMENT; OUTCOME ASSESSMENT; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; TREATMENT PLANNING;

ADENOCARCINOMA; BONE NEOPLASMS; ENDOSONOGRAPHY; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33748693296     PISSN: 15216918     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpg.2006.05.001     Document Type: Article

References (80)

1. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
2. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104 (1993) 510-513
3. Blot W.J., and McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 26 supplement 15 (1999) 2-8
4. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 347 (2002) 1662-1669
5. Rouvelas I., Zeng W., Lindblad M., et al. Survival after surgery for oesophageal cancer: a population-based study. Lancet Oncol 6 (2005) 864-870
6. Pera M. Epidemiology of esophageal cancer, especially adenocarcinoma of the esophagus and esophagogastric junction. Recent results. Cancer Res 155 (2000) 1-14
7. Enzinger P.C., and Mayer R.J. Esophageal cancer. N Engl J Med 125 (2003) 2241-2252
8. Eloubeidi M.A., Mason A.C., Desmond R.A., et al. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?. Am J Gastroenterol 98 (2003) 1627-1633
9. Taylor C.R. Carcinoma of the esophagus: current imaging options. Am J Gastroenterol 81 (1986) 1013-1020
10. In: Wittekind C., Greene F.L., Hutter R.V.P., et al. (Eds). TNM Atlas. 5th edn (2004), UICC Springer
11. Kato H., Kuwano H., Nakajima M., et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94 (2002) 921-928
12. Yoon Y.C., Lee K.S., Shim Y.M., et al. Metastasis to regional lymph nodes in patients with esophageal squamous cell carcinoma: CT versus FDG-PET for presurgical detection prospective study. Radiology 227 (2003) 764-770
13. Marriette C., Balon J.M., Maunoury V., et al. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 90 (2003) 1367-1372
14. Preston S.R., Clark G.W., Martin I.G., et al. Effect of endoscopic ultrasonography on the management of 100 consecutive patients with oesophageal and junctional carcinoma. Br J Surg 90 (2003) 1220-1224
15. Holden A., Mendelson R., and Edmunds S. Pre-operative staging of gastro-oesophageal junction carcinoma: comparison of endoscopic ultrasound and computed tomography. Australas Radiol 40 (1996) 206-212
16. Saunders H.S., Wolfman N.T., and Ott D.J. Esophageal cancer: radiologic staging. Radiol Clin North Am 35 (1997) 281-294
17. Heeren P.A., Jager P.L., Bongaerts F., et al. Detection of distant metastases in esophageal cancer with (18)F-FDG PET. J Nucl Med 45 (2004) 980-987
18. Flamen P., Lerut A., Van Cutsem E., et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 18 (2000) 3202-3210
19. van Westreenen H.L., Westerterp M., Bossuyt P.M., et al. Systematic review of the staging performance of 18 F-fluoroglucose positron emission tomography in esophageal cancer. J Clin Oncol 22 (2004) 3805-3812
20. Kole A.C., Plukker J.T., Nieweg O.E., et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 78 (1998) 521-527
21. Kim K., Park S.J., Kim B.T., et al. Evaluation of lymph node metastases in squamous cell carcinoma of the esophagus with positron emission tomography. Ann Thorac Surg 71 (2001) 290-294
22. Lerut T., Flamen P., Ectors N., et al. Histopathologic validation of lymph node staging within cancer of the esophagus and gastroesophageal junction: a prospective study based on primary resection with extensive lymphadenectomy. Ann Surg 232 (2000) 743-752
23. Flanagan F.L., Dehdashti F., Siegel B.A., et al. Staging of esophageal cancer with 18-F-fluorodexoglucose positron emission tomography. AJR Am J Roentgenol 64 (1997) 770-777
24. Kneist W., Schreckenberger M., Bartenstein P., et al. Prospective evaluation of positron emission tomography in the preoperative staging of esophageal carcinoma. Arch Surg 139 (2004) 1043-1049
25. Bar-Shalom R., Yefremov N., Guralnik L., et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med 44 (2003) 1200-1209
26. Antoch G., Saoudi N., Kuehl H., et al. Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-d-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET. J Clin Oncol 22 (2004) 4357-4368
27. DeMeester S.R. Lymph node involvement in esophageal adenocarcinoma: if you see one, have you seen them all?. J Thorac Cardiovasc Surg 126 (2003) 947-949
28. DeMeester T.R. Esophageal carcinoma: current controversies. Semin Surg Oncol 13 (1997) 217-233
29. Roder J.D., Busch R., Stein H.J., et al. Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the esophagus. Br J Surg 81 (1994) 410-413
30. Fockens P., Kisman K., Merkus M.P., et al. The prognosis of esophageal carcinoma staged irresectable (T4) by endosonography. J Am Coll Surg 186 (1998) 17-23
31. Patel A.N., and Buenaventura P.O. Current staging of esophageal carcinoma. Surg Clin North Am 85 (2005) 555-567
32. Hagen J.A., and DeMeester T.R. Staging of esophageal carcinoma. J Thorac Cardiovasc Surg 125 (2003) 988-991
33. Forastiere A.A., Orringer M.B., Perez-Tamayo C., et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 11 (1993) 1118-1123
34. Forastiere A.A., Heitmiller R.F., Lee D.J., et al. Intensive chemoradiation followed by transhiatal esophagectomy for squamous cell and adenocarcinoma of the esophagus. Cancer J Sci Am 3 (1997) 144-152
35. Lerut T., Coosemans W., Decker G., et al., Collaborate workgroup for esophageal carcinoma. Extracapsular lymph node involvement is a negative prognostic factor in T3 adenocarcinoma of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg 126 (2003) 1121-1128
36. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660-670
37. Westerterp M., Koppert I.B., Buskens C.J., et al. Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastroesophageal junction. Virchows Arch 44 (2005) 497-504
38. Stahl M., Vanhoefer U., Stuschke M., et al. Preoperative sequential chemo- and radiochemotherapy in locally advanced carcinomas of the lower oesophagus and gastro-oesophageal junction. Eur J Cancer 34 (1998) 668-673
39. Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337 (1997) 161-167
40. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335 (1996) 462-467
41. Rosch T., Lorenz R., Zenker K., et al. Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc 38 (1992) 460-467
42. Grimm H., Binmoeller K.F., Hamper K., et al. Endosonography for preoperative locoregional staging of esophageal and gastric cancer. Endoscopy 25 (1993) 224-230
43. Botet J.F., Lightdale C.J., Zauber A.G., et al. Preoperative staging of esophageal cancer: comparison of endoscopic US and dynamic CT. Radiology 181 (1991) 419-425
44. Romagnuolo J., Falck V., Urbanski S.J., et al. Helical CT versus EUS with fine needle aspiration for celiac nodal assessment in patients with esophageal cancer. Gastrointest Endosc 55 (2002) 648-654
45. Wren S.M., Stijns P., Srinivas S., et al. Positron emission tomography in the initial staging of esophageal cancer. Arch Surg 137 (2002) 1001-1007
46. Choi J.Y., Lee K.H., Shim Y.M., et al. Improved detection of individual nodal involvement in squamous cell carcinoma of the esophagus by FDG PET. J Nucl Med 41 (2000) 808-815
47. Ziegler K., Sanft C., Zeitz M., et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut 32 (1991) 16-20
48. Tio T.L., Coene P.P., den Hartog Jager F.C., et al. Preoperative TNM classification of esophageal carcinoma by endosonography. Hepatogastroenterology 37 (1990) 376-381
49. Lightdale C.J., and Kulkarni K.G. Role of endoscopic ultrasonography in the staging and follow-up of esophageal cancer. J Clin Oncol 20 (2005) 4483-4489 [Review]
50. Vazquez-Sequeiros E., Wiersema M.J., Clain J.E., et al. Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology 125 (2003) 1626-1635
51. Bonavina L., Incarbone R., Lattuada E., et al. Preoperative laparoscopy in management of patients with carcinoma of the esophagus and of the esophagogastric junction. J Surg Oncol 65 (1997) 171-174
52. Sugarbaker D.J., Jaklitsch M.T., Liptay M.J., et al. Thoracoscopic staging and surgical therapy for esophageal cancer. Chest 107 supplement 6 (1995) 218S-223S
53. Luketich J.D., Schauer P., Landreneau R., et al. Minimally invasive surgical staging is superior to endoscopic ultrasound in detecting lymph node metastases in esophageal cancer. J Thorac Cardiovasc Surg 114 (1997) 817-823
54. Greenberg J., Durkin M., Van Drunen M., et al. Computed tomography or endoscopic ultrasonography in preoperative staging of gastric and esophageal tumors. Surgery 116 (1994) 696-702
55. Kelly S., Harris K.M., Berry E., et al. A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma. Gut 49 (2001) 534-539
56. May A., Gunter E., Roth F., et al. Accuracy of staging in early oesophageal cancer using high resolution endoscopy and high resolution endosonography: a comparative, prospective, and blinded trial. Gut 53 (2004) 634-640
57. Reed C.E., Mishra G., Sahai A.V., et al. Esophageal cancer staging: improved accuracy by endoscopic ultrasound of celiac lymph nodes. Ann Thorac Surg 67 (1999) 319-322
58. Rice T.W. Clinical staging of esophageal carcinoma. CT, EUS, and PET. Chest Surg Clin N Am 10 (2000) 471-485
59. Salminen J.T., Färkkila M.A., Rämö O.J., et al. Endoscopic ultrasonography in the preoperative staging of adenocarcinoma of the distal oesophagus and oesophagogastric junction. Scand J Gastroenterol 34 (1999) 1178-1182
60. Wallace M.B., Nietert P.J., Earle C., et al. An analysis of multiple staging management strategies for carcinoma of the esophagus, computed tomography, endoscopic ultrasound, positron emission tomography and thoracoscopy/laparoscopy. Ann Thorac Surg 74 (2002) 1026-1032
61. van Dam J. Endosonographic evaluation of the patient with esophageal cancer. Chest 112 (1997) 184-190
62. Räsänen J.V., Sihvo F.I., Knuuti M.J., et al. Prospective analysis of accuracy of PET, CT and EUS in staging of adenocarcinoma of the esophagus and gastroesophageal cancer. Ann Surg Oncol 10 (2003) 954-960
63. Kato H., Miyazaki T., Nakajima M., et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer 103 (2005) 148-156
64. Yeung H.W., Macapinlac H.W., Mazumdar M., et al. FDG-PET in esophageal cancer. Incremental value over computer tomography. Clin Positron Imaging 2 (1999) 255-260
65. Luketich J.D., Friedman D.M., Weigel T.L., et al. Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans. Ann Thorac Surg 68 (1999) 1133-1136 and 1136-1137
66. Kneist W., Schreckenberger M., Bartenstein P., et al. Positron emission tomography for staging esophageal cancer: does it lead to a different approach?. World J Surg 27 (2003) 1105-1112
67. Westerterp M., van Westreenen H.L., Reitsma J.B., et al. Esophageal cancer: CT, endoscopic US and FDG-PET for assessment of response to neoadjuvant therapy: systemic review. Radiology 23 (2005) 841-851
68. Brucher B.L., Stein H.J., Zimmerman F., et al. Responders benefit from neoadjuvant radiochemotherapy in esophgeal squamous cell carcinoma: results of a prospective phase-II trial. Eur J Surg Oncol 31 (2004) 963-971
69. DeYoung C.M., Sunharalingam M., Line B.R., et al. The ability of whole body FDG18-PET imaging to predict pathologic response to induction chemoradiotherapy in locally advanced esophageal cancer. A prospective phase II trial. Int J Radiat Oncol Biol Phys 57 (2003) S165-S166
70. Wieder H.A., Brucher B.L., Zimmermann F., et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. J Clin Oncol 22 (2004) 900-908
71. Jones D.R., Detterbech F.C., Egan T.M., et al. Induction chemoradiotherapy followed by esophagectomy in patients with carcinoma of the esophagus. Ann Thorac Surg 64 (1997) 185-191
72. Weber W.A., Ott K., Becker K., et al. Prediction of response to preoperative chemotherapy in adenocarcinoma of the esophagogastric junction by metabolic imaging. J Clin Oncol 19 (2001) 3058-3065
73. Ott K., Fink U., Becker K., et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 21 (2003) 4604-4610
74. Quint L.E., Hepburn L.M., Francis I.R., et al. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer 76 (1995) 1120-1125
75. Halvorsen Jr. R.A., and Thompson W.M. CT of esophageal neoplasms. Radiol Clin North Am 27 (1989) 667-685
76. Meltzer U., Luketich J.D., Friedman D., et al. Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography. Clin Nucl Med 11 (2000) 882-887
77. Flamen P., Lerut T., Hausterman K., et al. Position of positron emission tomography and other imaging diagnostic modalities in esophageal cancer. Q J Nucl Med Mol Imaging 48 (2004) 96-108 [Review]
78. Block M.I., Patterson G.A., Sundaresan R.S., et al. Improvement in staging of esophageal cancer with the addition of positron emission tomography. Ann Thorac Surg 64 (1997) 770-776
79. Westerterp M., van Westreenen H.L., Sloof G.W., et al. Additional value of positron emission tomography in preoperative staging of esophageal cancer: a prospective cohort study. Eur J Gastroenterol Hepatol 18 1 (Jan. 2006) A1
80. Downey R.J., Akhurst T., Ilson D., et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 21 (2003) 428-432